Entity Common Stock, Shares Outstanding of Cogent Biosciences, Inc. from 30 Apr 2018 to 13 Feb 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Cogent Biosciences, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 30 Apr 2018 to 13 Feb 2026.
  • Cogent Biosciences, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 13 Feb 2026 was 162,308,820.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Cogent Biosciences, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 162,308,820 13 Feb 2026 10-K 17 Feb 2026 2025 FY
Q3 2025 142,376,529 +31,914,800 +29% 05 Nov 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 139,700,796 +30,250,333 +28% 01 Aug 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 113,856,454 +18,243,058 +19% 02 May 2025 10-Q 06 May 2025 2025 Q1
Q3 2024 110,461,729 +24,337,480 +28% 08 Nov 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 109,450,463 +23,985,214 +28% 02 Aug 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 95,613,396 +25,666,606 +37% 03 May 2024 10-Q 07 May 2024 2024 Q1
Q3 2023 86,124,249 +16,230,815 +23% 03 Nov 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 85,465,249 +19,706,983 +30% 04 Aug 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 69,946,790 +24,133,123 +53% 10 Mar 2023 10-K 14 Mar 2023 2022 FY
Q3 2022 69,893,434 +30,042,412 +75% 11 Nov 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 65,758,266 +25,909,462 +65% 05 Aug 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 45,813,667 +8,619,400 +23% 11 Mar 2022 10-K 15 Mar 2022 2021 FY
Q3 2021 39,851,022 +28,508,622 +251% 08 Nov 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 39,848,804 +1,585,677 +4.1% 13 Aug 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 37,194,267 +6,579,667 +21% 12 Mar 2021 10-K 16 Mar 2021 2020 FY
Q3 2020 11,342,400 -19,320,654 -63% 06 Nov 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 38,263,127 +7,602,573 +25% 07 Aug 2020 10-Q 11 Aug 2020 2020 Q2
Q1 2020 30,614,600 +495,778 +1.6% 23 Mar 2020 10-K 26 Mar 2020 2019 FY
Q3 2019 30,663,054 +673,582 +2.2% 08 Nov 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 30,660,554 +793,306 +2.7% 09 Aug 2019 10-Q 12 Aug 2019 2019 Q2
Q1 2019 30,118,822 +279,736 +0.94% 30 Apr 2019 10-Q 13 May 2019 2019 Q1
Q3 2018 29,989,472 31 Oct 2018 10-Q 13 Nov 2018 2018 Q3
Q2 2018 29,867,248 31 Jul 2018 10-Q 13 Aug 2018 2018 Q2
Q1 2018 29,839,086 30 Apr 2018 10-Q 14 May 2018 2018 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.